Skip Navigation

Viremia and Clinical Presentation in Nicaraguan Patients Infected with Zika Virus, Chikungunya Virus, and Dengue Virus

  1. Benjamin A. Pinsky1,5,#
  1. 1Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA
  2. 2Sustainable Sciences Institute, Managua, Nicaragua
  3. 3National Virology Laboratory, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua
  4. 4Department of Scientific Computing, Florida State University, Tallahassee, FL, USA
  5. 5Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
  6. 6Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
  1. #Corresponding Author: Benjamin A. Pinsky, 3375 Hillview Ave, Room 2913, Palo Alto, CA 94304. Phone: +001 (650) 721-1896, Fax: +001 (650) 723-6918, E-mail: bpinsky{at}stanford.edu.

Abstract

Background. Zika virus (ZIKV), chikungunya virus (CHIKV), and dengue virus (DENV) co-circulate in Nicaragua. In this study, we sought to compare the quantified viremia and clinical presentation of patients infected with one or more of these viruses.

Methods. Acute-phase serum samples from 346 patients with a suspected arboviral illness were tested using a multiplex real-time RT-PCR for ZIKV, CHIKV, and DENV. Viremia was quantitated for each detected virus, and clinical information was recorded from request forms submitted with each sample.

Results. Two hundred sixty-three patients tested positive for one or more viruses: 192 patients tested positive for a single virus (mono-infections) and 71 patients tested positive for two or all three viruses (co-infections). Quantifiable viremia was lower in ZIKV infections compared to CHIKV or DENV (mean 4.70 vs 6.42 and 5.84 log10 copies/mL serum, respectively; p<0.001 for both comparisons), and for each virus, mean viremia was significantly lower in co-infections than in mono-infections. Compared to patients with CHIKV or DENV, ZIKV patients were more likely to have a rash (p<0.001) and less likely to be febrile (p<0.05) or require hospitalization (p<0.001). Among all patients, hospitalized cases had higher viremia than those who did not require hospitalization (7.1 vs 4.1 log10 copies/mL serum, respectively; p<0.001).

Conclusions. ZIKV, CHIKV, and DENV result in similar clinical presentations, and co-infections may be relatively common. Our findings illustrate the need for accurate, multiplex diagnostics for patient care and epidemiologic surveillance.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, contact journals.permissions{at}oup.com.

UNCORRECTED PROOF

Published on behalf of

cid cover HIV Medicine Association Logo

Society Members: For your free access to this journal, log in via the IDSA members area.

Impact Factor: 8.886

5-Yr impact factor: 9.206

For Reviewers

Looking for your next opportunity?

Looking for jobs...

For the Media

Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.